Lawrence Rosenthal, MD
Gastroenterology · West Orange, NJNPI 1942359021
Payments from drug & device makers
Across 718 payments — averaging $13.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Bristol Myers Squibb$879
- Johnson & Johnson$785
- Pfizer$544
- Takeda Pharmaceuticals U.S.A., Inc.$506
- plus $3K from 30 others
What the payments were for
- Food & beverage$9,46099%
- Education$551%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 139 | $1,761 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 159 | $1,737 |
| Bristol Myers Squibb | 81 | $879 |
| Johnson & Johnson | 56 | $785 |
| Pfizer | 38 | $544 |
| Takeda Pharmaceuticals U.S.A., Inc. | 33 | $506 |
| Braintree Laboratories, Inc. | 26 | $494 |
| Merck | 19 | $269 |
| Ironwood Pharmaceuticals, Inc | 17 | $255 |
| Gilead | 17 | $221 |
| Intercept Pharmaceuticals, Inc. | 14 | $211 |
| Redhill Biopharma Inc. | 13 | $193 |
| Lilly USA, LLC | 10 | $182 |
| Aimmune Therapeutics, Inc. | 11 | $179 |
| Ferring Pharmaceuticals Inc. | 11 | $170 |
| Ardelyx, Inc. | 10 | $165 |
| Daiichi Sankyo Inc. | 11 | $154 |
| Evoke Pharma, Inc. | 9 | $147 |
| Celltrion USA Inc. | 7 | $121 |
| Phathom Pharmaceuticals, Inc. | 5 | $73 |
| Nestle Healthcare Nutrition Inc. | 5 | $70 |
| Regeneron Healthcare Solutions, Inc. | 3 | $47 |
| Sanofi | 2 | $47 |
| Novo Nordisk | 2 | $37 |
| Medtronic | 2 | $35 |
| Ipsen Biopharmaceuticals, Inc | 2 | $35 |
| Vivus LLC | 2 | $29 |
| Organon | 4 | $28 |
| QOL Medical, LLC | 2 | $28 |
| UCB, Inc. | 2 | $27 |
| Pentax Of America, Inc. | 1 | $18 |
| Fresenius Kabi USA, LLC | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $16 |
| Olympus America Inc. | 1 | $16 |
| W. L. Gore & Associates, Inc. | 1 | $12 |
| Micro-tech Endoscopy USA, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOTOFEN$111
- SUPREP BOWEL PREP$111
How this compares
$9,514 in reported general payments places this provider in the 80th percentile of 701 gastroenterology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 24 | $113,037 |
| Humira(Cf) PenAdalimumab | 13 | $90,454 |
| Dexlansoprazole DrDexlansoprazole | 43 | $17,335 |
| Mesalamine | 20 | $15,250 |
| PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C | 53 | $7,363 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 38 | $6,552 |
| Sucralfate | 19 | $6,486 |
| DexilantDexlansoprazole | 15 | $5,767 |
| Pantoprazole Sodium | 326 | $5,707 |
| NexiumEsomeprazole Magnesium | 18 | $4,629 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 26 | $4,208 |
| Lubiprostone | 13 | $2,848 |
| Omeprazole | 127 | $1,673 |
| Esomeprazole Magnesium | 43 | $1,133 |
| Famotidine | 31 | $495 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon | $1,761 | $113,03724 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCPlenvu | $1,737 | $7,36353 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $170 | $6,55238 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Dexilant | $506 | $5,76715 claims |
| Braintree Laboratories, Inc.Sutab | $494 | $4,20826 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 701 gastroenterology providers in New Jersey.
Other gastroenterology in West Orange
- Alexander PerelmanWest Orange$160K
- Robert SchumanWest Orange$39K
- Vitaly FishbeinWest Orange$26K
- Kiran RaoSparta$1.3M
- Adekunle AdeotiIrvington$1.2M
- Carl WallachMorristown$766K
- Vinod RustgiNew Brunswick$697K
- Arvind TrindadeNew Brunswick$652K
- Barry KaufmanEgg Harbor Township$595K
- Promila BanerjeeStratford$522K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.